IPO Traffic: Week Ending Oct. 12, 2018

Lead Manager/ # of Price Range Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Mercantil Bank Holding (MBNAA) Raymond James $225.00 n.a.
n.a. (not available)
Postponed
Osmotica Pharmaceuticals plc (OSMT) Jefferies/ Barclays/ RBC Capital Markets 8.30 $14.00 $16.00 $124.50 1-Star
None
Withdrawn
None
New Terms
Anaplan (PLAN) Goldman Sachs/ Morgan Stanley/ Barclays 15.50 $15.00 $17.00 $248.00 S/O
LogicBio Therapeutics (LOGC) Jefferies/ Barclays/ William Blair 5.77 $12.00 $14.00 $75.01 S/O
Niu Technologies (NIU) Credit Suisse/ Citigroup 8.30 $10.50 $12.50 $95.45 S/O
SharedLabs (SHLB) ThinkEquity (a division of Fordham Financial Management) 1.00 $5.00 $7.00 $6.00 S/O
Studio City International Holdings (MSC) Deutsche Bank Securities/ Credit Suisse/ Morgan Stanley 28.75 $10.50 $12.50 $330.63 S/O
S/O (Subscribers Only)
IPOs Priced Lead Shares Amount Offer Close %
Week of Oct. 8, 2018 Manager(s) Offered Raised Price 10/12/18 Change
Allogene Therapeutics (ALLO) Goldman Sachs/ J.P. Morgan/ Cowen/ Jefferies 18.00 $324.00 $18.00 $26.81 48.94%
Anaplan (PLAN) Goldman Sachs/ Morgan Stanley/ Barclays 15.50 $263.50 $17.00 $24.30 42.94%
DD3 Acquisition (DDMXU) (u) EarlyBirdCapital 5.00 $50.00 $10.00 $10.01 0.10%
Equillium (EQ) Jefferies/ Leerink Partners/ Stifel 4.67 $65.38 $14.00 $14.00 0.00%
Livent (LTHM) BofA Merrill Lynch/ Goldman Sach/ Credit Suisse 20.00 $340.00 $17.00 $16.25 -4.41%
u = unit offering